Stock SABS SAB BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions SAB Biotherapeutics, Inc.

Equities

SABS

US78397T2024

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
4.03 USD +0.25% Intraday chart for SAB Biotherapeutics, Inc. -5.17% -41.38%
04-16 SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update CI
04-02 HC Wainwright Adjusts Price Target on SAB Biotherapeutics to $6 From $10, Maintains Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. SABS Stock
  4. Revisions SAB Biotherapeutics, Inc.